The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network

Brianna Davies1, Jason D Roberts2, Rafik Tadros3,4

  • 1Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

CJC Open
|December 11, 2020
PubMed

Insights

The National HiRO Registry unites Canadian experts and patients to detect inherited heart conditions and prevent sudden cardiac death. This integrated platform supports research for better understanding and care of these at-risk individuals.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • The Hearts in Rhythm Organization (HiRO) comprises Canadian experts, genetic counselors, nurses, researchers, patients, and families focused on inherited arrhythmias and cardiomyopathies.
  • HiRO is dedicated to detecting these conditions, providing optimal therapies, and preventing sudden cardiac arrest.

Purpose of the Study:

  • To establish an integrated research platform for studying inherited heart rhythm and cardiomyopathy conditions.
  • To facilitate novel research questions aimed at improving the understanding, detection, and clinical care of affected individuals.
  • To ultimately prevent sudden cardiac death in patients with inherited heart conditions.

Main Methods:

  • Merging existing disease-specific registries into the expanded National HiRO Registry.
  • Creating a unified dataset for patients and families with inherited conditions posing a risk for sudden death in Canada.
  • Inviting eligible patients from 20 specialized cardiogenetics clinics across Canada to participate in the registry and optional biobank.

Main Results:

  • Currently, 4700 participants are enrolled in the National HiRO Registry.
  • An average of 593 participants have been enrolled annually over the past 5 years.
  • HiRO's infrastructure includes working groups supporting organizational goals, developed with patient partners, to enable knowledge translation.

Conclusions:

  • The National HiRO Registry serves as a crucial integrated research platform.
  • It enables researchers to investigate inherited heart conditions, leading to enhanced understanding and detection.
  • The ultimate goal is to improve clinical care and prevent sudden cardiac death in individuals with these conditions.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
133
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
288
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
3.3K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.2K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
197